Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'IMMUNODEFICIENCY-VIRUS TYPE-1' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 3977 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tian, HJ; Xiao, Y; Zhu, M; Chen, YH
      HIV epitope-peptides in aluminum adjuvant induced high levels of epitope-specific antibodies

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Murphy, PM
      Viral exploitation and subversion of the immune system through chemokine mimicry

      NATURE IMMUNOLOGY
    3. Folcik, RM; Merrill, JD; Li, Y; Guo, CJ; Douglas, SD; Starr, SE; Ho, WZ
      HIV-1 infection of placental cord blood monocyte-derived dendritic cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    4. Moriyama, K; Otsuka, C; Loakes, D; Negishi, K
      Highly efficient random mutagenesis in transcription-reversetranscription cycles by a hydrogen bond ambivalent nucleoside 5 '-triphosphate analogue: Potential candidates for a selective anti-retroviral therapy

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    5. Lobaton, E; Velazquez, S; Perez-Perez, MJ; Jimeno, ML; San-Felix, A; De Clercq, E; Balzarini, J; Camarasa, MJ
      "Second generation" of TSAO compounds directed against HIV-1 TSAO-resistant strains

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    6. Lobaton, E; Velazquez, S; San-Felix, A; De Clercq, E; Balzarini, J; Camarasa, MJ
      4 ''-H-TSAO-T, a novel prototype in the HIV-1 specific TSAO family

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    7. Miller, MD; Margot, NA; Hertogs, K; Larder, B; Miller, V
      Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    8. Ray, AS; Anderson, KS
      Mechanistic studies to understand the inhibition of wildtype and mutant HIV-1 reverse transcriptase by carbovir-triphosphate

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    9. Katzman, M; Harper, AL; Sudol, M; Skinner, LM; Eyster, ME
      Activity of HIV-1 integrases recovered from subjects with varied rates of disease progression

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Stuart, JWTC; Wensing, AMJ; Kovacs, C; Righart, M; de Jong, D; Kaye, S; Schuurman, R; Visser, CJT; Boucher, CAB
      Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Rollins, NC; Filteau, SM; Coutsoudis, A; Tomkins, AM
      Feeding mode, intestinal permeability, and neopterin excretion: A longitudinal study in infants of HIV-infected south African women

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Manfredi, R
      A cross-sectional survey of HIV genotype mutations conferring resistance to all nonnucleoside reverse transcriptase inhibitors and related features, at the time of failure of antiretroviral therapy in the real world

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Miller, MD; Margot, NA; Lamy, PD; Fuller, MD; Anton, KE; Mulato, AS; Cherrington, JM
      Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: Genotypic and phenotypic analyses of study GS-96-408

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    14. Ruiz, L; Negredo, E; Domingo, P; Paredes, R; Francia, E; Balague, M; Gel, S; Bonjoch, A; Fumaz, CR; Johnston, S; Romeu, J; Lange, J; Clotet, B
      Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    15. Bernasconi, E; Vernazza, PL; Bernasconi, A; Hirschel, B
      HIV transmission after suspension of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    16. Lemiale, F; Brand, D; Lebigot, S; Verrier, T; Buzelay, L; Brunet, S; Barin, F
      Immunogenicity of recombinant envelope glycoproteins derived from T-cell line-adapted isolates or primary HIV isolates - A comparative study using multivalent vaccine approaches

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    17. Weidle, PJ; Kityo, CM; Mugyenyi, P; Downing, R; Kebba, A; Pieniazek, D; Respess, R; Hertogs, K; De Vroey, V; Dehertogh, P; Bloor, S; Larder, B; Lackritz, E
      Resistance to antiretroviral therapy among patients in Uganda

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    18. Trichavaroj, R; de Souza, MS; Buapunth, P; Markowitz, L; Sukwit, S; Nitayaphan, S; Brown, AE
      HIV viral load in Thai men and women with subtype E infections

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    19. Roongpisuthipong, A; Siriwasin, W; Simonds, RJ; Sangtaweesin, V; Vanprapar, N; Wasi, C; Singhanati, S; Mock, P; Young, N; Parekh, B; Mastro, TD; Shaffer, N
      HIV seroconversion during pregnancy and risk for mother-to-infant transmission

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    20. Parry, JV; Murphy, G; Barlow, KL; Lewis, K; Rogers, PA; Belda, FJ; Nicoll, A; McGarrigle, C; Cliffe, S; Mortimer, PP; Clewley, JP
      National surveillance of HIV-1 subtypes for England and Wales - Design, methods, and initial findings

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    21. Talal, AH; Irwin, CE; Dieterich, DT; Yee, H; Zhang, LQ
      Effect of HIV-1 infection on lymphocyte proliferation in gut-associated lymphoid tissue

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    22. Briones, C; Perez-Olmeda, M; Rodriguez, C; del Romero, J; Hertogs, K; Soriano, V
      Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    23. Talal, AH; Monard, S; Vesanen, M; Zheng, ZY; Hurley, A; Cao, YZ; Fang, F; Smiley, L; Johnson, J; Kost, R; Markowitz, MH
      Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    24. Reisler, RB; Thea, DM; Pliner, V; Green, T; Lee, F; Nesheim, S; Brown, T; Kalish, M; Folks, TM; Heneine, W
      Early detection of reverse transcriptase activity in plasma of neonates infected with HIV-1: A comparative analysis with RNA-based and DNA-based testing using polymerase chain reaction

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    25. Demeter, L; Haubrich, R
      Phenotypic and genotypic resistance assays: Methodology, reliability, and interpretations

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    26. Sparacio, S; Pfeiffer, T; Schaal, H; Bosch, V
      Generation of a flexible cell line with regulatable, high-level expressionof HIV Gag/Pol particles capable of packaging HIV-derived vectors

      MOLECULAR THERAPY
    27. Saves, M; Morlat, P; Chene, G; Peuchant, E; Pellegrin, I; Bonnet, F; Bernard, N; Lacoste, D; Salamon, R; Beylot, J
      Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy

      CLINICAL IMMUNOLOGY
    28. Ledochowski, M; Murr, C; Widner, B; Fuchs, D
      Inverse relationship between neopterin and immunoglobulin E

      CLINICAL IMMUNOLOGY
    29. Kalinkovich, A; Borkow, G; Weisman, Z; Tsimanis, A; Stein, M; Bentwich, Z
      Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: Environmental and constitutive factors

      CLINICAL IMMUNOLOGY
    30. Lewin, AS; Hauswirth, WW
      Ribozyme gene therapy: applications for molecular medicine

      TRENDS IN MOLECULAR MEDICINE
    31. Levy, JA
      The importance of the innate immune system in controlling HIV infection and disease

      TRENDS IN IMMUNOLOGY
    32. Appay, V; Rowland-Jones, SL
      RANTES: a versatile and controversial chemokine

      TRENDS IN IMMUNOLOGY
    33. Pohlmann, S; Baribaud, F; Doms, RW
      DC-SIGN and DC-SIGNR: helping hands for HIV

      TRENDS IN IMMUNOLOGY
    34. Bush, RM
      Opinion - Predicting adaptive evolution

      NATURE REVIEWS GENETICS
    35. Morris, M; Nicoll, A; Simms, I; Wilson, J; Catchpole, M
      Bacterial vaginosis: a public health review

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    36. Geyer, M; Fackler, OT; Peterlin, BM
      Structure-function relationships in HIV-1 Nef

      EMBO REPORTS
    37. Gu, YM; LaBell, R; O'Brien, DF; Saavedra, SS
      Quantitative studies of binding between synthetic galactosyl ceramide analogues and HIV-1 Gp120 at planar membrane surfaces

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    38. Li, C; Dowd, CS; Zhang, W; Chaiken, IM
      Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences

      JOURNAL OF PEPTIDE RESEARCH
    39. Beck, A; Bussat, MC; Klinguer-Hamour, C; Goetsch, L; Aubry, JP; Champion, T; Julien, E; Haeuw, JF; Bonnefoy, JY; Corvaia, N
      Stability and CTL activity of N-terminal glutamic acid containing peptides

      JOURNAL OF PEPTIDE RESEARCH
    40. O'Hagan, DT; MacKichan, ML; Singh, M
      Recent developments in adjuvants for vaccines against infectious diseases

      BIOMOLECULAR ENGINEERING
    41. Clark, TN; White, CA; Chu, CK; Bartlett, MG
      Determination of 3 '-azido-2 ',3 '-dideoxyuridine in maternal plasma, amniotic fluid, fetal and placental tissues by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    42. Kamkamidze, G; Sullivan, T; Charbonneau, T
      Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants

      JOURNAL OF CLINICAL VIROLOGY
    43. Guimaraes, ML; Bastos, FI; Telles, PR; Galvao-Castro, B; Diaz, RS; Bongertz, V; Morgado, MG
      Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II

      JOURNAL OF CLINICAL VIROLOGY
    44. Koch, N; Tamalet, C; Tivoli, N; Fantini, J; Yahi, N
      Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase

      JOURNAL OF CLINICAL VIROLOGY
    45. Savarino, A; Gennero, L; Sperber, K; Boelaert, JR
      The anti-HIV-1 activity of chloroquine

      JOURNAL OF CLINICAL VIROLOGY
    46. Bogh, M; Machuca, R; Gerstoft, J; Pedersen, C; Obel, N; Kvinesdal, B; Nielsen, H; Nielsen, C
      Subtype-specific problems with qualitative Amplicor HIV-1 DNA PCR test

      JOURNAL OF CLINICAL VIROLOGY
    47. Gambari, R
      Peptide-nucleic acids (PNAs): A tool for the development of gene expression modifiers

      CURRENT PHARMACEUTICAL DESIGN
    48. Leitner, WW; Hammerl, P; Thalhamer, J
      Nucleic acid for the treatment of cancer: Genetic vaccines and DNA adjuvants

      CURRENT PHARMACEUTICAL DESIGN
    49. Mwakagile, D; Nimari, E; Makwaya, C; Mbwana, J; Biberfeld, G; Mhalu, F; Sandstrom, E
      Sexual behaviour among youths at high risk for HIV-1 infection in Dar es Salaam, Tanzania

      SEXUALLY TRANSMITTED INFECTIONS
    50. Seck, K; Samb, N; Tempesta, S; Mulanga-Kabeya, C; Henzel, D; Sow, PS; Coll-Seck, A; Mboup, S; Ndoye, I; Delaporte, E
      Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 andHIV-2 infected women in Dakar, Senegal

      SEXUALLY TRANSMITTED INFECTIONS
    51. Lever, AML
      Gene therapy for HIV

      SEXUALLY TRANSMITTED INFECTIONS
    52. Kowalski, J
      A non-parametric approach to translating gene region heterogeneity associated with phenotype into location heterogeneity

      BIOINFORMATICS
    53. Frith, MC; Hansen, U; Weng, ZP
      Detection of cis-element clusters in higher eukaryotic DNA

      BIOINFORMATICS
    54. Van Vaerenbergh, K; Debaisieux, L; De Cabooter, N; Declercq, C; Desmet, K; Fransen, K; Maes, B; Marissens, D; Miller, K; Muyldermans, G; Sprecher, S; Stuyver, L; Vaira, D; Verhofstede, C; Zissis, G; Van Ranst, M; De Clercq, E; Desmyter, J; Vandamme, AM
      Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium

      ANTIVIRAL THERAPY
    55. Kijak, GH; Pampuro, SE; Avila, MM; Zala, C; Cahn, P; Wainberg, MA; Salomon, H
      Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina

      ANTIVIRAL THERAPY
    56. Lange, J
      A rational approach to the selection and sequencing of nucleoside/nucleotide analogues: a new paradigm

      ANTIVIRAL THERAPY
    57. Miller, V
      Interpretation of resistance assay results

      ANTIVIRAL THERAPY
    58. Race, E
      Cross-resistance within the protease inhibitor class

      ANTIVIRAL THERAPY
    59. Hoetelmans, R
      Pharmacological exposure and the development of drug resistance in HIV

      ANTIVIRAL THERAPY
    60. Berkhout, B; Vastenhouw, NL; Klasens, BIF; Huthoff, H
      Structural features in the HIV-1 repeat region facilitate strand transfer during reverse transcription

      RNA-A PUBLICATION OF THE RNA SOCIETY
    61. Svitkin, YV; Pause, A; Haghighat, A; Pyronnet, S; Witherell, G; Belsham, GJ; Sonenberg, N
      The requirement for eukaryotic initiation factor 4A (eIF4A) in translationis in direct proportion to the degree of mRNA 5 ' secondary structure

      RNA-A PUBLICATION OF THE RNA SOCIETY
    62. Kammler, S; Leurs, C; Freund, M; Krummheuer, J; Seidel, K; Tange, TO; Lund, MK; Kjems, J; Scheid, A; Schaal, H
      The sequence complementarity between HIV-1 5 ' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA

      RNA-A PUBLICATION OF THE RNA SOCIETY
    63. Ross, HL; Gartner, S; McArthur, JC; Corboy, JR; McAllister, JJ; Millhouse, S; Wigdahl, B
      HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity

      JOURNAL OF NEUROVIROLOGY
    64. Neamati, N
      A small-molecule antagonist of virion assembly

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    65. Neamati, N
      Structure-based HIV-1 integrase inhibitor design: a future perspective

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    66. Peeters, M
      The genetic variability of HIV-1 and its implications

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    67. Barboric, M; Nissen, RM; Kanazawa, S; Jabrane-Ferrat, N; Peterlin, BM
      NF-kappa B binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II

      MOLECULAR CELL
    68. Moniaux, N; Escande, F; Porchet, N; Aubert, JP; Batra, SK
      Structural organization and classification of the human mucin genes

      FRONTIERS IN BIOSCIENCE
    69. Macara, IG
      Transport into and out of the nucleus

      MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
    70. Okui, N; Kitamura, Y; Kobayashi, N; Sakuma, R; Ishikawa, T; Kitamura, T
      Virion-targeted viral inactivation: New therapy against viral infection

      MOLECULAR UROLOGY
    71. D'Anna, R; Le Buanec, H; Bizzini, B; Burny, A; Giannouli, C; Zagury, JF; Gallo, RC; Zagury, D; D'Alessio, P
      Human papillomavirus-16-E7 oncoprotein enhances the expression of adhesionmolecules in cervical endothelial cells but not in human umbilical vein endothelial cells

      JOURNAL OF HUMAN VIROLOGY
    72. Kozinetz, CA
      Epidemiology of HIV/AIDS in developing countries: The children

      AIDS PATIENT CARE AND STDS
    73. Gupta, S; Arora, K; Sampath, A; Singh, SS; Gupta, A; Chaudhary, VK
      Mapping of HIV-1 Gag epitopes recognized by polyclonal antibodies using gene-fragment phage display system

      PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY
    74. Hatzakis, A; Gargalianos, P; Kiosses, V; Lazanas, M; Sypsa, V; Anastassopoulou, C; Vigklis, V; Sambatakou, H; Botsi, C; Paraskevis, D; Stalgis, C
      Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: Evidence of potent suppression of viral replication

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    75. Stoddart, CA; Liegler, TJ; Mammano, F; Linquist-Stepps, VD; Hayden, MS; Deeks, SG; Grant, RM; Clavel, F; McCune, JM
      Impaired replication of protease inhibitor-resistant HIV-1 in human thymus

      NATURE MEDICINE
    76. Koup, RA
      A new latent HIV reservoir

      NATURE MEDICINE
    77. Brooks, DG; Kitchen, SG; Kitchen, CMR; Scripture-Adams, DD; Zack, JA
      Generation of HIV latency during thymopoiesis

      NATURE MEDICINE
    78. Matte, C; Roger, M
      Genetic determinants of pediatric HIV-1 infection: Vertical transmission and disease progression among children

      MOLECULAR MEDICINE
    79. Mochida-Nishimura, K; Surewicz, K; Cross, JV; Hejal, R; Templeton, D; Rich, EA; Toossi, Z
      Differential activation of MAP kinase signaling pathways and nuclear factor-kappa B in bronchoalveolar cells of smelters and nonsmokers

      MOLECULAR MEDICINE
    80. Simmons, A; Aluvihare, V; McMichael, A
      Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators

      IMMUNITY
    81. Tobin, MJ
      Asthma, airway biology, and allergic rhinitis in AJRCCM 2000

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    82. Gilbert, PB; Novitsky, VA; Montano, MA; Essex, M
      An efficient test for comparing sequence diversity between two populations

      JOURNAL OF COMPUTATIONAL BIOLOGY
    83. Choi, JK; Hoang, N; Vilardi, AM; Conrad, P; Emerson, SG; Gewirtz, AM
      Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors inhuman CD34(+) hematopoietic cells

      STEM CELLS
    84. Wang, JJ; Sandefur, S; Spearman, P; Chiou, CT; Chiang, PH; Ratner, L
      Tracking the assembly pathway of human immunodeficiency virus type 1 Gag deletion mutants by immunogold labeling

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    85. Rusnati, M; Urbinati, C; Musulin, B; Ribatti, D; Albini, A; Noonan, D; Marchisone, C; Waltenberger, J; Presta, M
      Activation of endothelial cell mitogen activated protein kinase ERK1/2 by extracellular HIV-1 Tat protein

      ENDOTHELIUM-NEW YORK
    86. Brooking, J; Davis, SS; Illum, L
      Transport of nanoparticles across the rat nasal mucosa

      JOURNAL OF DRUG TARGETING
    87. Swart, PJ; Kuipers, ME; Smit, C; Beljaars, L; Ter Wiel, J; Meijer, DKF
      The metabolic fate of the anti-HIV active drug carrier succinylated human serum albumin after intravenous administration in rats

      JOURNAL OF DRUG TARGETING
    88. John, L; Marra, F; Ensom, MHH
      Role of therapeutic drug monitoring for protease inhibitors

      ANNALS OF PHARMACOTHERAPY
    89. Whitney, CG; Schaffner, W; Butler, JC
      Rethinking recommendations for use of pneumococcal vaccines in adults

      CLINICAL INFECTIOUS DISEASES
    90. Hawley-Foss, N; Mbisa, G; Lum, JJ; Pilon, AA; Angel, JB; Garber, G; Badley, AD
      Effect of cessation of highly active antiretroviral therapy during a discordant response: Implications for scheduled therapeutic interruptions

      CLINICAL INFECTIOUS DISEASES
    91. Hanna, GJ; D'Aquila, RT
      Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy

      CLINICAL INFECTIOUS DISEASES
    92. Gagneux, P; Varki, A
      Genetic differences between humans and great apes

      MOLECULAR PHYLOGENETICS AND EVOLUTION
    93. Iyer, RK; Kim, PS; Bando, JM; Lu, KV; Gregg, JP; Grody, WW
      A multiethnic study of Delta 32ccr5 and ccr2b-V64I allele distribution in four Los Angeles populations

      DIAGNOSTIC MOLECULAR PATHOLOGY
    94. Grizzle, WE; Fredenburgh, J
      Avoiding biohazards in medical, veterinary and research laboratories

      BIOTECHNIC & HISTOCHEMISTRY
    95. Piguet, V; Trono, D
      Living in oblivion: HIV immune evasion

      SEMINARS IN IMMUNOLOGY
    96. Dugas, N; Lacroix, C; Kilchherr, E; Delfraissy, JF; Tardieu, M
      Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis

      CYTOKINE
    97. Patel, L; Charlton, SJ; Chambers, JK; Macphee, CH
      Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations

      CYTOKINE
    98. Biswas, P; Mantelli, B; Delfanti, F; Cota, M; Vallanti, G; De Filippi, C; Mengozzi, M; Vicenzi, E; Lazzarin, A; Poli, G
      Tumor necrosis factor-alpha drives HIV-1 replication in U937 cell clones and upregulates CXCR4

      CYTOKINE
    99. Farson, D; Witt, R; McGuinness, R; Dull, T; Kelly, M; Song, JP; Radeke, R; Bukovsky, A; Consiglio, A; Naldini, L
      A new-generation stable inducible packaging cell line for lentiviral vectors

      HUMAN GENE THERAPY
    100. Fuller, M; Anson, DS
      Helper plasmids for production of HIV-1-derived vectors

      HUMAN GENE THERAPY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/02/20 alle ore 09:19:38